Auctus Fund LLC 13D/13G Filings for Zevra Therapeutics, Inc. (ZVRA)

Auctus Fund LLC 13D and 13G filings for Zevra Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-02-12
2:23 pm
Sale
2021-02-08 13G Zevra Therapeutics, Inc.
ZVRA
Auctus Fund LLC 450,000
2.380%
-550,000decrease
(-55.00%)
Filing
2021-02-05
2:04 pm
Purchase
2021-01-26 13G Zevra Therapeutics, Inc.
ZVRA
Auctus Fund LLC 1,000,000
8.580%
1,000,000increase
(New Position)
Filing